Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kayentis logo — Simplify your clinical trial experience

Kayentis

Simplify your clinical trial experience

Founded 2003 France France 161 employees Debt Financing Pharmaceutical

General Information

Company Name Kayentis
Founded Year 2003
Location France France +2
Employees 161
Industries Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when Kayentis moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kayentis

Kayentis is a global provider of eCOA and Decentralized Clinical Trial solutions, aiming to simplify and streamline the collection of clinical trial data for pharmaceutical, biotech, and CROs. With a history dating back to 2003, the company specializes in eCOA solutions for phases I-IV across various therapeutic areas. Additionally, it has expanded its portfolio to support decentralized and hybrid trials, reflecting the evolving landscape of clinical research. Kayentis boasts an impressive track record, having conducted digital data collection for over 300 clinical trials in 90 countries, catering to 100,000 patients in 120 languages. The company operates from offices in the US (Boston), France (Grenoble), and Japan (Tokyo), employing 185 staff. Notably, its most recent milestone was a Debt Financing investment on 28 March 2023. Although the specific details of this investment are undisclosed, it indicates investor confidence in Kayentis' offerings and potential for growth within the pharmaceutical industry.

Taxonomy: eCOA solutions, Decentralized Clinical Trial solutions, Clinical Trials, Patient engagement, Electronic Clinical Outcome Assessments, DCT solutions, ePRO, eDiary, Televisit, Digital Data Collection, Therapeutic Areas, Hybrid Trials, Clinical Development, Pharma, Biotech

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 28 Mar 2023
Venture - Series Unknown •••••• - 02 Dec 2020
Venture - Series Unknown •••••• - 19 Oct 2016
Venture - Series Unknown •••••• - 24 Feb 2015
Venture - Series Unknown •••••• - 10 May 2011

View All 7 Funding Rounds

Kayentis Alternatives & Competitors

Kayentis vs
Clinical ink
Clinical ink United States

Clinical ink is the global life science company that brings data, technology, and patient-centric re...

Series Unknown
255 employees
Health Care, Information Technology
Compare Kayentis vs Clinical ink
Kayentis vs
TrialX
TrialX United States

The patient connection.

28 employees
Health Care
Compare Kayentis vs TrialX
Kayentis vs
CRF Health
CRF Health

Enhancing clinical trials with innovative eCOA solutions for diverse therapeutic areas worldwide

Private Equity
Biotechnology, Health Care
Compare Kayentis vs CRF Health

FAQ About Kayentis

Simplify your clinical trial experience
Kayentis was founded in 2003.
Kayentis is headquartered in France.
Kayentis operates in the following industries: Pharmaceutical.
Kayentis has approximately 161 employees.
Kayentis has completed 7 funding rounds. The latest funding stage is Debt Financing.
Top alternatives and competitors to Kayentis include Clinical ink, TrialX, CRF Health, ObvioHealth, Datacubed Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kayentis and Clinical ink are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kayentis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy